HLGEX | VMGIX | HLGEX / VMGIX | |
Total Expense Ratio | 0.84 | 0.19 | 442% |
Annual Report Gross Expense Ratio | 0.94 | 0.19 | 495% |
Fund Existence | 37 years | 19 years | - |
Gain YTD | 10.191 | 13.334 | 76% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13B | 32.3B | 40% |
Annual Yield % from dividends | 0.00 | 0.51 | - |
Returns for 1 year | 13.73 | 25.14 | 55% |
Returns for 3 years | 42.34 | 55.52 | 76% |
Returns for 5 years | 18.03 | 62.58 | 29% |
Returns for 10 years | 83.76 | 184.28 | 45% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 143.12 | 2.77 | +1.97% |
iShares Biotechnology ETF | |||
VGM | 9.71 | 0.16 | +1.68% |
Invesco Trust Investment Grade Municipals | |||
IPB | 25.72 | 0.02 | +0.06% |
Merrill Lynch Depositor | |||
UJUN | 36.36 | -0.03 | -0.08% |
Innovator U.S. Equity Ultra BffrETF™-Jun | |||
CANQ | 29.41 | -0.04 | -0.15% |
Calamos Nasdaq® Equity & Income ETF |